Deborah Coon
Nurse Practitioner · Rockledge, FLNPI 1699058263
Payments from drug & device makers
Across 139 payments — averaging $29.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$381
- Abbott$294
- Mannkind Corporation$241
- AstraZeneca$235
- Dexcom, Inc.$165
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $1,011 |
| Lilly USA, LLC | 6 | $381 |
| Abbott | 13 | $294 |
| Mannkind Corporation | 14 | $241 |
| AstraZeneca | 2 | $235 |
| Dexcom, Inc. | 3 | $165 |
| AbbVie | 3 | $156 |
| Esperion Therapeutics, Inc. | 5 | $141 |
| Tandem Diabetes Care, Inc. | 1 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $116 |
| Johnson & Johnson | 1 | $112 |
| Amgen | 7 | $105 |
| Biohaven Pharmaceuticals, Inc. | 1 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $99 |
| Amarin Pharma, Inc. | 6 | $96 |
| Medtronic | 2 | $90 |
| Nevro Corp. | 1 | $89 |
| IBSA Pharma Inc. | 4 | $72 |
| Xeris Pharmaceuticals, Inc. | 4 | $66 |
| Radius Health, Inc. | 3 | $59 |
| Stimwave Technologies Incorporated | 1 | $59 |
| Zealand Pharma US, Inc. | 3 | $52 |
| Insulet Corporation | 2 | $39 |
| Bayer | 2 | $35 |
| Boehringer Ingelheim | 2 | $35 |
| Novartis | 2 | $33 |
| Pfizer | 1 | $25 |
| Antares Pharma, Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$235
- NURTEC ODT$216
- Ozempic$215
- t:slim X2 Insulin Pump with Control-IQ$140
- Saxenda$125
- TRULICITY$125
- FREESTYLE LIBRE 3$123
- XARELTO$112
- UBRELVY$111
- Wegovy$100
How this compares
$4,125 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 946 | $1,456,884 |
| JardianceEmpagliflozin | 606 | $641,396 |
| Tresiba Flextouch U-100Insulin Degludec | 562 | $331,712 |
| Tresiba Flextouch U-200Insulin Degludec | 145 | $168,554 |
| MounjaroTirzepatide | 133 | $165,708 |
| Novolog FlexpenInsulin Aspart | 307 | $89,480 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 67 | $89,385 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 55 | $79,573 |
| RybelsusSemaglutide | 43 | $73,435 |
| FarxigaDapagliflozin Propanediol | 62 | $71,801 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 93 | $70,966 |
| TrulicityDulaglutide | 40 | $69,198 |
| TymlosAbaloparatide | 20 | $57,416 |
| ForteoTeriparatide | 11 | $49,939 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 44 | $40,393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus, Novolog | $1,011 | $1,641,9131,149 claims |
| Boehringer IngelheimJardiance | $35 | $641,396606 claims |
| Lilly USA, LLCMounjaro, Trulicity, Forteo, Humalog | $381 | $293,403207 claims |
| AstraZenecaFarxiga | $235 | $71,80162 claims |
| Radius Health, Inc.Tymlos | $59 | $57,41620 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $17 | $40,39344 claims |
| Johnson & JohnsonInvokana | $112 | $20,89820 claims |
| AbbVieSynthroid | $156 | $10,453120 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $11 | $9,327539 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Rockledge
- Kathryn ShunnarahRockledge$22K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.